2007
31
Oct
Sanofi-aventis Announces a Good Third Quarter Performance … - Earthtimes
|
Sanofi-aventis Announces a Good Third Quarter Performance …
Earthtimes, UK - Net sales of Acomplia(R) were euro 21 million in the third quarter and euro 58 million to end September. Results from clinical trials have shown that … |
More: continued here